ADVFN
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,268.56
      0.14%
      US Tech 100
      22,227.20
      0.27%
      Dow Jones
      44,459.65
      0.20%
      Brent Oil
      68.375
      -0.33%
      Bitcoin
      117,225.77
      -2.23%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Amneal Pharmaceuticals Holding Co (AMRX)

      7. Amneal Pharmaceuticals Holding Co (AMRX) Financials

      Amneal Pharmaceuticals Holding Co

      Amneal Pharmaceuticals Holding Co (AMRX)

      Amneal Pharmaceuticals Inc
      5.87
      0.00
      (0.00%)
      Closed July 15 4:00PM
      15 min delayed - Upgrade to Realtime
      0.00
      0.00
      (0.00%)
      After Hours: -
      15 min delayed - Upgrade to Realtime

      Amneal Pharmaceuticals Holding Co (AMRX) Financials

      Amneal Pharmaceuticals Holding Co Financial Summary

      The current AMRX market cap is 1.82B. The company's latest EPS is USD -0.3776 and P/E is -15.55.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 659.19M701.78M702.47M730.52M700.54M
      Operating Income -10.65M95.47M87.78M75.79M100.35M
      Net Income -91.64M5.99M-156k-31.08M12.2M
      Year End December 30 2024 20202021202220232024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 1.99B2.09B2.22B2.41B2.79B
      Operating Income 91.16M158.08M-96.84M204.37M248.4M
      Net Income 91.06M10.62M-129.99M-83.99M-116.89M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 3.46B3.51B3.46B3.5B3.37B
      Total Liabilities 3.47B3.51B3.49B3.55B3.42B
      Total Equity -63.63M-57.49M-93.57M-109.51M-132M
      Year End December 30 2024 20202021202220232024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 4.01B3.94B3.8B3.47B3.5B
      Total Liabilities 3.65B3.56B3.59B3.41B3.55B
      Total Equity 344.93M366.97M183.98M20.01M-109.51M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -4.41M35.25M177.02M295.1M7.41M
      Investing -19.76M-26.23M-46.94M-63M-17.8M
      Financing -23.16M-58.24M-150.59M-211.79M-39.17M
      Year End December 30 2024 20202021202220232024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 379M241.82M65.1M345.58M295.1M
      Investing -317.55M-194.18M-174.31M-69.19M-63M
      Financing 131.81M-138.12M-106.62M-212.57M-211.79M

      Stats and Ratios

      Market Cap 1.82B
      Price to Earnings Ratio -15.55
      Price to Sales Ratio 0.65
      Price to Cash Ratio 16.44
      Price to Book Ratio -40.8
      Dividend Yield -

      Share Statistics

      Shares Outstanding 309.54M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 0.29 (4.87%)

      Company Info

      Company Name Amneal Pharmaceuticals Holding Co
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.amneal.com
      Industry pharmaceutical preparations (2834)

      Your Recent History

      NYSE
      AMRX
      Amneal Pharmaceuticals
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads